Cholesterol-PEG2K-Gemcitabine

Cholesterol-PEG2K-Gemcitabine refers to a specific conjugate molecule involving the attachment of gemcitabine, a chemotherapy drug used to treat various cancers, to a cholesterol derivative that is connected to a polyethylene glycol (PEG) spacer.

This cholesterol-PEG2K-gemcitabine conjugate is designed to improve the solubility, stability, and targeted delivery of gemcitabine, potentially increasing its effectiveness in cancer treatment while minimizing adverse side effects. The specific PEG spacer length and cholesterol modification may vary depending on the intended application and desired properties of the conjugate.

msds of Cholesterol-PEG2K-Gemcitabine